Orlistat

This classification denotes a gastrointestinal lipase inhibitor with the molecular formula C29H53NO5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 95M8R751W8, chemically known as n-formyl-l-leucine, ester with (3s,4s)-3-hexyl-4-((2s)-2-hydroxytridecyl)-2-oxetanone but generally known as orlistat, which bears US NIH Compound Identifier 3034010. European Medicines Agency schedules Orlistat in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09460MIG. The term ORLISTAT is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 6, No, 3 1992, List 32). World Health Organization schedules orlistat in its Anatomical Therapeutic Chemical (ATC) Classification. ORLISTAT is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. As of Q4 2014, ORLISTAT remains the US FDA Preferred Term for this commodity. Orlistat bears US NLM identifiers UMLS ID C0732649 and NCI Concept Code C29303. SMILES: O1C(C(CCCCCC)C1=O)CC(OC(=O)C(NC=O)CC(C)C)CCCCCCCCCCC.